These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1149 related articles for article (PubMed ID: 8230621)
21. Positive predictive value of specific mammographic findings according to reader and patient variables. Venkatesan A; Chu P; Kerlikowske K; Sickles EA; Smith-Bindman R Radiology; 2009 Mar; 250(3):648-57. PubMed ID: 19164116 [TBL] [Abstract][Full Text] [Related]
22. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602 [TBL] [Abstract][Full Text] [Related]
23. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926 [TBL] [Abstract][Full Text] [Related]
24. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia. Randall D; Morrell S; Taylor R; Hung WT Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941 [TBL] [Abstract][Full Text] [Related]
25. Comparing the performance of mammography screening in the USA and the UK. Smith-Bindman R; Ballard-Barbash R; Miglioretti DL; Patnick J; Kerlikowske K J Med Screen; 2005; 12(1):50-4. PubMed ID: 15814020 [TBL] [Abstract][Full Text] [Related]
26. Spectrum of mammographically detected breast cancers. Sener SF; Winchester DJ; Winchester DP; Kurek R; Motykie G; Martz CH; Rabbitt S Am Surg; 1999 Aug; 65(8):731-5; discussion 735-6. PubMed ID: 10432082 [TBL] [Abstract][Full Text] [Related]
27. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening. Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for breast cancer in women undergoing mammography. Reuter KL; Baker SP; Krolikowski FJ AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780 [TBL] [Abstract][Full Text] [Related]
29. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088 [TBL] [Abstract][Full Text] [Related]
30. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R; J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730 [TBL] [Abstract][Full Text] [Related]
31. Comparison of screening mammography in the United States and the United kingdom. Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948 [TBL] [Abstract][Full Text] [Related]
32. Digital Compared with Screen-Film Mammography: Measures of Diagnostic Accuracy among Women Screened in the Ontario Breast Screening Program. Prummel MV; Muradali D; Shumak R; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ; Chiarelli AM Radiology; 2016 Feb; 278(2):365-73. PubMed ID: 26334680 [TBL] [Abstract][Full Text] [Related]
33. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of modern screening mammography. Kerlikowske K; Barclay J J Natl Cancer Inst Monogr; 1997; (22):105-11. PubMed ID: 9709285 [TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285 [TBL] [Abstract][Full Text] [Related]
36. [Incidence of breast cancer before and after implementation of mammography screening]. Hofvind S; Sørum R; Haldorsen T; Langmark F Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191 [TBL] [Abstract][Full Text] [Related]
37. The natural history of invasive breast cancers detected by screening mammography. Zahl PH; Maehlen J; Welch HG Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493 [TBL] [Abstract][Full Text] [Related]
38. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004. Paajanen H; Kyhälä L; Varjo R; Rantala S Am Surg; 2006 Feb; 72(2):167-71. PubMed ID: 16536250 [TBL] [Abstract][Full Text] [Related]
39. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581 [TBL] [Abstract][Full Text] [Related]